A Study of ASP1951 in Subjects With Advanced Solid Tumors

Clinical trial NCT03799003 · TERMINATED

Trial details

NCT number: NCT03799003
Sponsor: Astellas Pharma Global Development, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2019-01-14
Primary completion: 2023-07-06
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.